文献速递脑血管病外科

未破裂颅内动脉瘤对比增强的客观量化:高分辨率血管壁成像验证研究

Objective quantification of contrast enhancement of unruptured intracranial aneurysms: a high-resolution vessel wall imaging validation study.
PubMed 文献 · J Neurosurg · 2020-02-07

该研究基于爱荷华大学HR-VWI项目数据库,纳入80例患者共102个未破裂颅内动脉瘤,比较三种量化动脉瘤壁强化方法,并以动脉瘤大小≥7 mm作为不稳定的替代指标。结果显示CRstalk使用最大信号强度值是最可靠的客观量化方法,不同制造商及不同场强磁共振扫描仪间获得相同比值。

要点

  • CRstalk使用最大信号强度值是量化未破裂颅内动脉瘤HR-VWI强化的最可靠客观方法。
  • 动脉瘤≥7 mm组三种强化指标均显著高于<7 mm组(p<0.001)。
  • 3T GE与3T Siemens扫描仪间CRstalk相关性优秀(Pearson系数>0.80,p<0.001)。

核心结论

  • 使用最大信号强度值的CRstalk是量化未破裂颅内动脉瘤HR-VWI强化的最可靠客观方法。
  • 不同制造商及不同场强磁共振扫描仪间获得相同比值。

研究设计与样本

  • 分析爱荷华大学HR-VWI项目数据库,该数据库前瞻性纳入使用3T MRI扫描仪行HR-VWI的未破裂颅内动脉瘤患者。
  • 共纳入80例患者102个未破裂颅内动脉瘤,平均年龄64.5±12.2岁,女性64例(80%)。
  • 比较三种测量方法:动脉瘤强化比AER、动脉瘤与垂体柄对比比CRstalk、动脉瘤强化指数AEI。
  • 以动脉瘤大小≥7 mm作为不稳定的替代指标进行ROC曲线分析。
  • 9个未破裂颅内动脉瘤使用3T GE和3T Siemens扫描仪行相同HR-VWI方案,3个未破裂颅内动脉瘤另在7T GE扫描仪行第三次扫描。

主要发现

  • 动脉瘤≥7 mm组与<7 mm组比较:AER=0.82 vs 0.49(p<0.001);CRstalk=0.84 vs 0.61(p<0.001);AEI=0.81 vs 0.48(p<0.001)。
  • ROC曲线显示最佳灵敏度:CRstalk≥0.60为81.5%,AEI≥0.50为75.9%,AER≥0.49为74.1%。
  • 3T GE与3T Siemens扫描仪间CRstalk使用平均和最大信号强度值的相关性优秀(Pearson系数>0.80,p<0.001)。
  • 3个在7T GE扫描的未破裂颅内动脉瘤中也发现类似相关性。

关键数值与推荐

  • 动脉瘤强化比AER=(SI壁增强后-SI壁增强前)/SI壁增强前。
  • 动脉瘤与垂体柄对比比CRstalk=SI壁增强后/SI垂体柄增强后。
  • 动脉瘤强化指数AEI=([SI壁增强后/SI脑增强后]-[SI壁增强前/SI脑增强前])/(SI壁增强前/SI脑增强前)。
  • 以动脉瘤大小≥7 mm作为不稳定的替代指标。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: High-resolution vessel wall imaging (HR-VWI) has emerged as a valuable tool in assessing unruptured intracranial aneurysms (UIAs). There is no standardized method to quantify contrast enhancement of the aneurysm wall. Contrast enhancement can be objectively measured as signal intensity (SI) or subjectively adjudicated. In this study, the authors compared the different methods to quantify wall enhancement of UIAs and determined the sensitivity and specificity of each method as a surrogate of aneurysm instability. They also compared SI quantification between scanners from different manufacturers. METHODS: The University of Iowa HR-VWI Project database was analyzed. This database compiles patients with UIAs who prospectively underwent HR-VWI using a 3T MRI scanner. The mean and maximal SI values of the aneurysm wall, pituitary stalk, and genu of the corpus callosum were used to compare 3 different measurement methods: 1) aneurysm enhancement ratio AER = (SIwall post - SIwall pre)/SIwall pre; 2) aneurysm-to-pituitary stalk contrast ratio CRstalk = SIwall post/SIstalk post; and 3) aneurysm enhancement index AEI = ([SIwall post/SIbrain post] - [SIwall pre/SIbrain pre])/(SIwall pre/SIbrain pre) (where "pre" indicates precontrast images and "post" indicates postcontrast images). Size ≥ 7 mm was used as a surrogate of aneurysm instability for receiver operating characteristic (ROC) curve analysis. To determine if the objective quantification of SI varies among scanners from different manufacturers, 9 UIAs underwent the same HR-VWI protocol using a 3T General Electric (GE) scanner and a 3T Siemens scanner. Three UIAs also underwent a third scanning procedure on a unit with a different magnet strength (7T GE). RESULTS: Eighty patients with 102 UIAs were included in the study. The mean age was 64.5 ± 12.2 years, and 64 (80%) patients were women. UIAs ≥ 7 mm had significantly higher SIs than smaller UIAs (< 7 mm): AER = 0.82 vs 0.49, p < 0.001; CRstalk = 0.84 vs 0.61, p < 0.001; and AEI = 0.81 vs 0.48, p < 0.001. ROC curves demonstrated optimal sensitivity of 81.5% for CRstalk ≥ 0.60, 75.9% for AEI ≥ 0.50, and 74.1% for AER ≥ 0.49. Intermanufacturer correlation between 3T GE and 3T Siemens MRI scanners for CRstalk using mean and maximal SI values was excellent (Pearson coefficients > 0.80, p < 0.001). A similar correlation was identified among the 3 UIAs that underwent 7T imaging. CONCLUSIONS: CRstalk using maximal SI values was the most reliable objective method to quantify enhancement of UIAs on HR-VWI. The same ratios were obtained between different manufacturers and on scans obtained using magnets of different strengths.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Roa JA, Zanaty M, Osorno-Cruz C, et al. Objective quantification of contrast enhancement of unruptured intracranial aneurysms: a high-resolution vessel wall imaging validation study. J Neurosurg. 2020. PMID: 32032948. doi:10.3171/2019.12.JNS192746

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。